REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biopronec CIA Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Biopronec CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Biopronec CIA Ltda is a company based in Ecuador, with its head office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on January 18, 2008. It currently has a total number of 53 (2023) employees. In 2023, the company reported a net sales revenue drop of 7.73%. Its total assets decreased by 0.18% over the same period. The enterprise’s net profit margin increased by 1.15% in 2023.

Headquarters
Jose Carollo Oe1-238
Quito; Pichincha;

Contact Details: Purchase the Biopronec CIA Ltda report to view the information.

Website: http://www.pronavit.com

Basic Information
Total Employees:
Purchase the Biopronec CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Biopronec CIA Ltda report to view the information.
Registered Capital:
Purchase the Biopronec CIA Ltda report to view the information.
Incorporation Date:
January 18, 2008
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
47%
Purchase this report to view the information.
45%
Purchase this report to view the information.
4%
Purchase this report to view the information.
4%
Company Performance
Financial values in the chart are available after Biopronec CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-7.73%▼
Total operating revenue
-7.73%▼
Operating profit (EBIT)
48.04%▲
EBITDA
34.25%▲
Net Profit (Loss) for the Period
117.6%▲
Total assets
-0.18%▼
Total equity
3.74%▲
Operating Profit Margin (ROS)
1.35%▲
Net Profit Margin
1.15%▲
Return on Equity (ROE)
1.73%▲
Debt to Equity Ratio
-10.99%▼
Quick Ratio
0.04%▲
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo